These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9191527

  • 41. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD, Korcum AF, Pestereli E, Erdogan G, Karaveli S, Savas B, Griffith TS, Sanlioglu S.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):716-23. PubMed ID: 17512128
    [Abstract] [Full Text] [Related]

  • 42. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J.
    J Surg Res; 2007 Jun 01; 140(1):109-14. PubMed ID: 17291532
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
    Tan A, Bitterman P, Sonenberg N, Peterson M, Polunovsky V.
    Oncogene; 2000 Mar 09; 19(11):1437-47. PubMed ID: 10723135
    [Abstract] [Full Text] [Related]

  • 44. Impaired protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4E in muscle and eIF2B in liver.
    Lang CH, Frost RA, Kumar V, Wu D, Vary TC.
    Alcohol Clin Exp Res; 2000 Mar 09; 24(3):322-31. PubMed ID: 10776669
    [Abstract] [Full Text] [Related]

  • 45. Progression of eIF4e gene amplification and overexpression in benign and malignant tumors of the head and neck.
    Haydon MS, Googe JD, Sorrells DS, Ghali GE, Li BD.
    Cancer; 2000 Jun 15; 88(12):2803-10. PubMed ID: 10870064
    [Abstract] [Full Text] [Related]

  • 46. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.
    Yang W, Klos KS, Zhou X, Yao J, Yang Y, Smith TL, Shi D, Yu D.
    Cancer; 2003 Sep 15; 98(6):1123-30. PubMed ID: 12973835
    [Abstract] [Full Text] [Related]

  • 47. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS.
    Cancer; 2000 Mar 15; 88(6):1403-9. PubMed ID: 10717623
    [Abstract] [Full Text] [Related]

  • 48. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.
    Nathan CO, Franklin S, Abreo FW, Nassar R, de Benedetti A, Williams J, Stucker FJ.
    Laryngoscope; 1999 Aug 15; 109(8):1253-8. PubMed ID: 10443829
    [Abstract] [Full Text] [Related]

  • 49. Augmentation of wound healing with translation initiation factor eIF4E mRNA.
    Schwarz KW, Murray MT, Sylora R, Sohn RL, Dulchavsky SA.
    J Surg Res; 2002 Apr 15; 103(2):175-82. PubMed ID: 11922732
    [Abstract] [Full Text] [Related]

  • 50. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G, Porichis F, Sourvinos G, Vassilaros S, Spandidos DA.
    Cancer Lett; 2006 Apr 08; 235(1):100-13. PubMed ID: 15949894
    [Abstract] [Full Text] [Related]

  • 51. Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia.
    DeFatta RJ, Turbat-Herrera EA, Li BD, Anderson W, De Benedetti A.
    Int J Cancer; 1999 Feb 09; 80(4):516-22. PubMed ID: 9935150
    [Abstract] [Full Text] [Related]

  • 52. High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.
    Byrnes K, White S, Chu Q, Meschonat C, Yu H, Johnson LW, Debenedetti A, Abreo F, Turnage RH, McDonald JC, Li BD.
    Ann Surg; 2006 May 09; 243(5):684-90; discussion 691-2. PubMed ID: 16633004
    [Abstract] [Full Text] [Related]

  • 53. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
    Hsu HS, Chen HW, Kao CL, Wu ML, Li AF, Cheng TH.
    Ann Surg Oncol; 2011 May 09; 18(5):1469-77. PubMed ID: 21080085
    [Abstract] [Full Text] [Related]

  • 54. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma.
    Hu A, Sun M, Yan D, Chen K.
    Tumori; 2014 May 09; 100(5):541-6. PubMed ID: 25343550
    [Abstract] [Full Text] [Related]

  • 55. Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines.
    West MJ, Sullivan NF, Willis AE.
    Oncogene; 1995 Dec 21; 11(12):2515-24. PubMed ID: 8545108
    [Abstract] [Full Text] [Related]

  • 56. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer.
    Bellahcène A, Merville MP, Castronovo V.
    Cancer Res; 1994 Jun 01; 54(11):2823-6. PubMed ID: 8187059
    [Abstract] [Full Text] [Related]

  • 57. [The expression and correlation of eIF4E and VEGF in laryngeal squamous cell carcinoma].
    Wang B, Zhang H, Chen Y.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun 01; 19(11):501-3. PubMed ID: 16124648
    [Abstract] [Full Text] [Related]

  • 58. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J.
    J Clin Oncol; 1999 Sep 01; 17(9):2909-14. PubMed ID: 10561370
    [Abstract] [Full Text] [Related]

  • 59. Expression of eukaryotic initiation factor 4 E in hypopharyngeal carcinoma.
    Han M, Wang W, Wang L, Jiang Y.
    J Int Med Res; 2014 Aug 01; 42(4):976-83. PubMed ID: 24840750
    [Abstract] [Full Text] [Related]

  • 60. eIF4E expression in tumors: its possible role in progression of malignancies.
    De Benedetti A, Harris AL.
    Int J Biochem Cell Biol; 1999 Jan 01; 31(1):59-72. PubMed ID: 10216944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.